RNS No 3513u
CELSIS INTERNATIONAL PLC
3rd June 1998


CELSIS INTERNATIONAL PLC ("The Company")

As previously announced, Mr Arthur Holden resigned as a
director and chief executive of the Company on 12th May 1998,
having informed the Board of his interest in exploring options
such as acquiring or taking the Company private.  Mr Holden
has now notified the Board that he does not intend to make an
offer for the whole Company.  Instead, he has offered to
acquire for cash the Celsis Laboratory Group (CLG), the
Company's laboratory services business.  The Board, in
consultation with its advisors, has considered Mr Holden's
offer for CLG and has rejected it.  Accordingly, there are no
continuing discussions with Mr Holden.

A number of other parties have expressed interest in entering
into discussions with the Company, which may or may not lead
to an offer for the Company.  Although the Board is not
seeking a purchaser for the Company, it is reviewing each of
these expressions of interest with its advisors to assess
whether pursuing any of them would be in the best interests of
the Company and its shareholders.  A further announcement will
be made in due course.

All enquiries should be directed to:

Chris Evans (Chairman)             +44 (0)1873 812028
Mark Harris (Finance Director)          +44 (0)1223 426008


END

MSCBIGBLLXGCCID
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.